Iambic Therapeutics alternatives and competitors
The closest alternatives to Iambic Therapeutics are Relay Therapeutics, XtalPi, Verge Labs and Iktos.
Clinical stage drug discovery company in San Diego whose platform pairs two named model families with automated laboratories.
10 alternatives to Iambic Therapeutics
What each product does, with its price as the vendor publishes it.
-
R
Clinical stage precision medicine company in Cambridge, Massachusetts (Nasdaq: RLAY), built around the Dynamo platform and an approach it calls motion based drug design: proteins move, binding sites appear only in particular conformational states, and a discovery method anchored to static…
Price: Not applicable
-
X
XtalPi is a drug and materials discovery company founded in Boston in 2015 by three MIT postdoctoral physicists, headquartered in Shenzhen and listed on the Hong Kong Stock Exchange (2228) since 2024.
Price: No published price
-
V
Clinical stage biotechnology company now trading as Verge Labs, applying machine learning to human tissue derived multiomic data in neurology.
-
I
Iktos is a Paris generative AI and robotics company for small molecule drug discovery, founded in 2016.
Price: No published price
-
I
Insilico Medicine is a generative AI drug discovery company (HKEX: 3696), headquartered in Cambridge, Massachusetts with operations in Hong Kong, Abu Dhabi and Shanghai, that both licenses software and develops its own medicines.
Price: No published price
-
I
Isomorphic Labs is a London based AI drug design company founded in 2021 by Sir Demis Hassabis, who leads it as chief executive.
Price: Not applicable
-
R
Recursion (Nasdaq: RXRX) is a Salt Lake City drug discovery company built around the Recursion OS, which pairs automated wet labs running up to 2 million experiments a week with machine learning foundation models trained on the resulting 50 petabyte plus dataset of cellular images…
Price: Not applicable
-
S
Superluminal Medicines chases the same target class as Nabla Bio and Antiverse and attacks it from the opposite direction.
Price: No published price
-
T
Terray Therapeutics is a Los Angeles small molecule company whose founding argument is about data rather than models. Its chief executive Jacob Berlin put it plainly at the Series A: even the most powerful artificial intelligence cannot get past insufficient or unclear data.
Price: Not applicable
-
E
Enveda is a clinical stage biotechnology company in Boulder, Colorado that uses AI to discover medicines from the chemistry of living things.
Price: Not applicable
Iambic Therapeutics alternatives, answered
What are the best alternatives to Iambic Therapeutics?
The closest alternatives to Iambic Therapeutics are Relay Therapeutics, XtalPi, Verge Labs, Iktos and Insilico Medicine. XtalPi is a drug and materials discovery company founded in Boston in 2015 by three MIT postdoctoral physicists, headquartered in Shenzhen and listed on the Hong Kong Stock Exchange (2228) since 2024. Clinical stage biotechnology company now trading as Verge Labs, applying machine learning to human tissue derived multiomic data in neurology. Iktos is a Paris generative AI and robotics company for small molecule drug discovery, founded in 2016.
Who are Iambic Therapeutics's competitors?
Iambic Therapeutics's competitors in the Drug Discovery AI category include Relay Therapeutics, XtalPi, Verge Labs, Iktos, Insilico Medicine and Isomorphic Labs.